Ridgetech Inc.RDGT
Price (close)
$0.91
Market cap
—
P/E
—
Revenue (FY)
$132.2M
Net income
-$1.3M
Dividend yield
—
1-year total return
-99.5%
Net margin
-0.9%
Revenue growth
10.2%
Debt / equity
—
What Ridgetech Inc. does.
in the Cayman Islands that conducts substantially all of its business operations in China. Following the disposition of our wholly-owned
subsidiary, Jiuxin Investment and its owned or controlled entities, we have divested our retail pharmacy business, and shifted our focus
to the wholesale business of pharmaceutical products in China, both online and offline. We currently operate in the offline wholesale
Revenue and profit, by fiscal year.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Revenue | $133.1M | $164.4M | $120.2M | $124.0M | $120.0M | $132.2M |
| Net income | -$8.1M | -$3.2M | -$21.1M | -$4.2M | $10.2M | -$1.3M |
| Free cash flow | -$189,058 | -$5.5M | -$3.4M | -$3.5M | $1.1M | -$1.4M |
More on RDGT.
- Ridgetech Inc. summary
- Ridgetech Inc. financial statements
- Ridgetech Inc. key metrics
- Ridgetech Inc. health scores and style box
- Ridgetech Inc. earnings
- Ridgetech Inc. dividends
- Ridgetech Inc. valuation
- Ridgetech Inc. ownership and insiders
- Ridgetech Inc. peers
Figures from Ridgetech Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.